MONOPHARMA — Mono Pharmacare Cashflow Statement
0.000.00%
Last trade - 00:00- IN₹150.18m
- IN₹705.71m
- IN₹1.66bn
Annual cashflow statement for Mono Pharmacare, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | 2026 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | ARS | ARS | ARS |
| Standards: | IAS | IAS | IAS | IAS | IAS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 5.51 | 16.8 | 32.3 | 44.6 | 10.8 |
| Depreciation | |||||
| Non-Cash Items | 7.42 | 13.2 | 30.8 | 40.3 | 33.2 |
| Other Non-Cash Items | |||||
| Changes in Working Capital | -11.6 | -421 | -152 | -129 | -22.2 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 2.4 | -389 | -87.7 | -43 | 23 |
| Capital Expenditures | -0.14 | -6.33 | -1.75 | -2.26 | -0.045 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 0 | -5.88 | 5.74 | 0 | 0 |
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -0.14 | -12.2 | 3.98 | -2.26 | -0.045 |
| Financing Cash Flow Items | -7.42 | -13.2 | 22.4 | -39.7 | -32.8 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -1.54 | 403 | 83.2 | 48.6 | -20.1 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 0.715 | 1.73 | -0.55 | 3.35 | 2.86 |